ProShare Advisors’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154K | Sell |
10,707
-10
| -0.1% | -$144 | ﹤0.01% | 1782 |
|
|
2025
Q1 | $73.9K | Sell |
10,717
-3,228
| -23% | -$22.3K | ﹤0.01% | 1891 |
|
|
2024
Q4 | $74K | Buy |
+13,945
| New | +$74K | ﹤0.01% | 2123 |
|
|
2022
Q1 | – | Sell |
-10,240
| Closed | -$38K | – | 2316 |
|
|
2021
Q4 | $38K | Buy |
+10,240
| New | +$38K | ﹤0.01% | 2313 |
|
|
2021
Q3 | – | Sell |
-12,158
| Closed | -$120K | – | 2297 |
|
|
2021
Q2 | $120K | Buy |
12,158
+1,111
| +10% | +$11K | ﹤0.01% | 2268 |
|
|
2021
Q1 | $103K | Buy |
+11,047
| New | +$103K | ﹤0.01% | 2161 |
|